The information highlighted (if any) are the most recent updates for this brand.
SIDAPVIA is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and sitagliptin is appropriate (see Interactions and Pharmacology: Pharmacodynamics: Clinical trials under Actions).